Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Brookdale appoints Nick Stengle as CEO: Can he turn occupancy gains into EBITDA growth? Brookdale names Nick Stengle CEO as occupancy rises and guidance improves. Find out what it means for EBITDA, BKD stock, and the 2026 playbook—read now! byPallavi MadhirajuOctober 2, 2025